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Abstract The internalisation of metabotropic glutamate recep-
tor (mGluRla) and its splice variant (mGluRip), in response to 
agonist and phorbol esters (PMA), has been studied. Both 
mGluRla and mGluRip exhibit a similar rate of internalisation 
following PMA treatment, with a shift in their distribution from 
plasma membrane to endosome-enriched membrane fractions. 
Agonist challenge however caused a rapid loss, within 5-10 min, 
of mGluRip but not mGluRla from the cell surface. These 
results show that the two forms of mGluRl show different 
internalisation responses to agonist and suggest that the C-
terminal region of the molecule plays an important role in this 
phenomenon. 
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1. Introduction 
Metabotropic glutamate receptors (mGluRs) constitute a 
family of large G-protein coupled receptors which show little 
sequence homology with the superfamily of smaller G-protein 
linked receptors [1]. Eight members of the mGluR family have 
been identified, several of which generate different subtypes by 
alternative mRNA splicing [2]. These eight mGluR receptors 
and their subtypes may be categorised into three subgroups 
on the basis of their sequence homology, agonist selectivity 
and signal transduction pathway. The first group contains 
mGluRl and mGluR5 which share the strongest sequence 
homology (62% identical at the amino acid level), are coupled 
to phospholipase C in transfected cells, and quisqualic acid 
(Quis) is their most potent agonist. Five splice variants of 
mGlurl have been described, namely mGluRla, mGluRip, 
mGluRlc, mGluRld and mGluRle [2-A]. In mGluRip, the 
insertion of an 85 base sequence in the carboxy-terminal tail 
introduces a stop codon that results in a 318 amino acid 
deletion and also changes the reading frame resulting in a 
different C-terminal amino acid sequence from that of 
mGluRla. The functional significance of the different splice 
variants has not yet been fully explored. It has been suggested 
that the C-termini of mGluRs, which are intracellular, might 
play a role in the subcellular targeting of the receptor [5] and 
elements of the C-terminus close to the inner surface of the 
plasma membrane have been shown to be important for G-
protein coupling [2]. 
G-protein coupled receptors undergo homologous [6] and 
heterologous desensitisation [7]. In the former the receptor 
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loses its responsiveness to a subsequent stimulation after acti-
vation by its agonist, in the latter responsiveness is lost after 
activation of a different receptor or cell signalling pathway. 
Receptor desensitisation is a complex process which can in-
volve phosphorylation of the molecule, its uncoupling from 
G-proteins, its internalisation/sequestration, and ultimately its 
down-regulation. However, the role of receptor internalisation 
in the process of desensitisation is not well defined. Desensi-
tisation can occur independently of internalisation, and con-
sequently other functions have been attributed to receptor 
internalisation, such as a role in receptor re-sensitisation [8,9]. 
In this study we have examined the internalisation of 
mGlurl a and mGlurl P, in response to quisqualic acid and 
phorbol 12-myristate 13-acetate (PMA) treatment, using per-
manently transfected BHK cells. Cell surface receptor was 
monitored using 12oI-labelled antibodies raised against N-ter-
minal epitopes of mGluRl. This together with immunoblot-
ting of different membrane fractions following challenge of 
the cells with PMA and quisqualic acid has allowed us to 
delineate the kinetics of internalisation of mGluRla and 
mGluRip and to show that these two subtypes of mGluR 
exhibit different internalisation responses to quisqualic acid. 
2. Materials and methods 
2.1. Antibodies 
Two antisera were used in this study. One, designated Rl, was 
raised against four synthetic peptides based on N-terminal sequences 
present in mGluRl, namely residues 59-75, 124-140, 139-157 and 
367-385. This pseudo-polyclonal antiserum was affinity purified as 
previously described [10]. All the initial experiments were performed 
with this antibody and confirmed using the second antibody described 
below. 
The second serum, Fl, was raised against a histidine tagged fusion 
protein containing an amino-terminal sequence of mGluRl, residues 
121-341. This was produced by cloning an EcoRl-Hindlll fragment of 
pmGRl [11] encoding these residues into the bacterial expression 
vector pET-28a+ (Novagen, Inc.). Induction and purification of the 
fusion protein was performed as recommended by the manufacturers. 
Two rabbits were inoculated subcutaneously with 0.5 mg of the fusion 
protein in Freund's complete adjuvant, and subsequent injections 
were performed every 4 weeks using Freund's incomplete adjuvant. 
Blood was taken 10 days after each injection. In order to affinity 
purify the specific antibodies, the same fragment (amino acid residues 
121-341 of rat mGluRl) was subcloned into the pGEX-4Tl bacterial 
expression vector (Pharmacia Biotech) and the resulting GST fusion 
protein was purified on glutathione agarose (Sigma). These sera were 
affinity purified on a cyanogen bromide coupled GST fusion protein 
column. Affinity purified antibody (Fl-Ab) was eluted using low pH 
as described previously [12] and dialyzed against phosphate buffered 
saline (PBS). 
2.2. Radioiodination of Rl-Ab and Fl-Ab 
The affinity purified antibodies (5 ug) were radiolabelled with 125I 
(100 uCi) (ICN) using chloramine-T [13]. The reaction product 
([12oI]Rl-Ab) was separated from free 12oI by chromatography on a 
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PD-10 Sephadex G-25 fine grade column (Pharmacia). Elution was 
performed with phosphate-buffered saline (PBS), pH 7.4 containing 
1% bovine serum albumin (BSA). The specific activity was routinely 
2.5-3.35 X109 dpm/nmol. 
2.3. Tissue culture 
BHK 570 cells stably expressing the mGluRla or mGluRlp recep-
tor were grown as previously described [10]. Membranes of cells were 
prepared by shearing cells in 10 mM NaHCC>3 as previously described 
[14] and protein was measured by the bicinchoninic acid method [15]. 
2.4. SDS-PAGE and immunoblotting 
Cell membranes were treated with SDS-PAGE sample buffer [12], 
before loading onto the polyacrylamide gels. Electrophoresis was per-
formed using 7.5% polyacrylamide gels [16]. Proteins were transferred 
to PVDF membranes (Immobilon-P, Millipore), using a semi-dry 
transfer system [17]. After blocking with 5% (w/v) dry milk in PBS 
containing 0.05% Tween-20 (PBS-T), PVDF membranes were washed 
in PBS-T and incubated overnight at 4°C with the specific affinity 
purified Rl or Fl antibody (2-4 ug/ml) in TBS-T-milk. Immunoreac-
tive bands were detected with swine anti-rabbit antibody conjugated 
to horseradish peroxidase followed by chemiluminescence detection 
(Amersham) [12]. 
2.5. Radioiodinated antibody binding experiments 
For internalisation experiments, cells were grown in glutamate free 
medium (ICN) in the absence of both glutamine and glutamic acid for 
3 h before the addition of 100 uM quisqualic acid or 1 uM PMA. 
After the indicated incubation time, cells were quickly chilled at 4°C, 
washed in cold PBS and fixed in 4% paraformaldehyde in PBS for 15 
min at room temperature. Cells were washed in PBS containing 20 
mM glycine (buffer A) to quench the aldehyde groups. After 30 min 
incubation in buffer A containing 1% BSA (buffer B), cells were in-
cubated with 1 ug/ml of [125I]R1-Ab or [125I]F1-Ab overnight at 4°C. 
Cells were washed five times with buffer B, disrupted with 1% SDS 
and the bound radioactivity determined using a Beckmann LS 5000 
CE scintillation counter. 
2.6. Sucrose gradients 
High- and low-density membranes were separated on sucrose step 
gradients as previously described [18]. Membranes at the 15-38% 
sucrose interface (low-density fraction) and 38-60% sucrose interface 
(high-density fraction) were collected, diluted with water and centri-
fuged at 100000 Xg for 1 h at 4°C. Pellets were resuspended in 50 ul 
of 10 mM NaHCC>3 and the protein concentration was determined as 
described above. The receptors were detected by immunoblotting us-
ing Rl-Ab. 
The immunoblots were quantified by densitometric scanning. The 
band intensities on X-ray film corresponding to mGlurla and 
mGlurlfS (monomer+dimer) receptors were measured using the vol-
ume integration function of the computer program NIH Image. The 
results are expressed as the percentages of the total receptor (high-
density fraction+low-density fraction) in each treatment. 
Fig. 1. Immunoblot showing expression of mGluRloc and mGluRlp 
in permanently transfected BHK cells. Twenty to 40 ug of protein 
from cell membranes were applied to 7.5% SDS-PAGE gels; the 
proteins were transferred to PVDF and the blots were incubated 
with Rl (A) or Fl (B). Lane 1, BHK cells permanently transfected 
with mGluRloc; lane 2, BHK cells permanently transfected with 
mGluRlp. 
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Fig. 2. Binding of [126I]R1-Ab to BHK cells permanently transfected 
with mGluRloc (□) or mGluRip ( 0 ) receptor subtypes. Perma-
nently transfected BHK cells were grown in glutamate free medium 
for 3 h before the addition of 1 U.M PMA (A) or 100 uM quis-
qualic acid (B) for the indicated time. Cells were processed as indi-
cated in Section 2 and then incubated overnight at 4°C with 1 ug/ 
ml of [125I]R1-Ab. The radioactivity that remained bound to the 
cells after washing was counted. Values are the mean ± S.E.M. of 
quadruplicate determinations. Similar results were obtained in three 
different experiments. 
3. Results 
Two antibodies raised against protein sequences in the ami-
no terminus of mGluRl have been used in this study. One 
generated using four synthetic peptides contained in this re-
gion of the molecule (termed Rl) and the other raised against 
a fusion protein containing the amino acid residues 121-341 
of rat mGluRl (termed Fl) . Both antibodies immunoblotted a 
major immunoreactive protein of apparent molecular weight 
of 150 kDa in membranes prepared from a BHK cell line 
permanently transfected for mGluRloc (Fig. 1), together 
with higher molecular weight bands which may represent 
oligomers of the receptor. In membranes prepared from a 
BHK cell line containing mGluRip, the Rl and Fl yielded 
two immunoreactive bands, with apparent molecular weights 
of 190 kDa and 94 kDa (Fig. 1), which may correspond to 
receptor dimer and monomer respectively. These results are in 
good agreement with previously reported studies using the 
BHK cell lines and with the results obtained with other anti-
bodies to these receptors [10-19]. 
The effect of quisqualic acid, a full agonist of mGluRl, and 
the protein kinase C activator, PMA, on receptor cell surface 
expression was examined. Following activation for varying 
times by the different agents the cells were quickly chilled, 
fixed, and the amount of receptors remaining on the cell sur-
face determined by [125I]R1 binding. BHK mGluRla and 
BHK mGluRip containing cell lines showed a similar time-
course of internalisation (^ 1/2 = 18 ± 6 min and 32 ±8 min, 
respectively) in response to PMA (Fig. 2A), with maximal 
internalisation (~20%) of mGluRla or mGluRlp after a 
45 min exposure to 1 (J.M PMA. When cells where activated 
with 100 \xM quisqualic acid the time-course of surface recep-
tor loss in the two cell lines was completely different. BHK 
cells containing mGluRip showed a rapid loss of receptor (up 
to ~25%), within 5 min, followed by a slow recovery reach-
ing ~ 90% of the initial receptor density after a 3 h exposure 
to the agonist. BHK cells containing mGluRla did not show 
detectable receptor loss following a short time exposure to 
agonist (Fig. 2B). Similar results were observed when the oth-
er N-terminal antibody [125I]F1 was used (data not shown). 
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Fig. 3. Receptor internalization of mGluRla and mGluRip in 
BHK cells as detected by immunoblotting. BHK cells permanently 
transfected with mGluRla (A) or mGluRip" (B) were grown in glu-
tamate free medium for 3 h before the addition of 1 |xM PMA 
(PMA), 100 uM quisqualic acid (Quis) or vehicle (Control) for 45 
min (A) or 5 min and 45 min (B). Cells were quickly chilled at 4°C 
and high- (H) and low-density (L) membranes were separated on a 
sucrose gradient (see Section 2). 20 ug of protein from each fraction 
was applied to 7.5% SDS-PAGE gels and the receptor present was 
detected by immunoblotting using the Rl antibody. Similar results 
were obtained in three different experiments. 
The different behaviour of the two receptor subtypes in 
response to quisqualic acid exposure suggests that the region 
responsible for agonist mediated fast internalisation of 
mGluRip is located in the last 22 amino acids of mGluRip. 
In order to confirm that the loss of cell surface receptor 
described above was due to receptor internalisation we pre-
pared cellular fractions enriched in plasma membranes and 
endosomal compartments from cells exposed to either PMA 
or quisqualic acid. 
In control BHK mGluRla cells the percentage of receptor 
present in the low-density membrane fraction was consistently 
around 50% of the total receptor (Fig. 3A, Control), as de-
termined by densitometric scanning of the immunoblot of the 
corresponding fractionated membranes. After activation of 
PKC for 45 min with 1 uM PMA there was a shift ranging 
from 20-30% of mGluRla from the high- to the low-density 
membrane fraction in three different experiments (Fig. 3A). 
However, quisqualic acid treatment of the cells caused no 
significant alteration in the distribution of mGluRla in mem-
brane fractions (Fig. 3A). 
When BHK cells containing mGluRip cells were similarly 
examined two activation times of drug intervention were chos-
en, namely 5 and 45 min, in order to study the fast agonist 
effect on surface mGluRip expression described above. In the 
BHK cells permanently transfected with mGluRip the 
amount of receptor present in the low-density membrane frac-
tion was consistently about 32 ± 2% of the total receptor (Fig. 
3B). Activation of PKC with 1 uM PMA revealed a time 
dependent redistribution of receptor from high- to the low-
density fraction (Fig. 3B). Densitometry of immunoblots in 
three different experiments indicated that the amount of total 
receptor in the low density membrane fraction increased by 
10-15% after 5 min and by 15-20% after 45 min of PMA 
treatment. The appearance of the lower molecular weight 
bands in the PMA treated lanes, especially noticeable after 
45 min may reflect the degradation of the receptor after entry 
of at least some of it, into the lysosomal compartment. In 
contrast, when the cells where activated with 100 uM quis-
qualic acid the amount of receptor in the low density fraction 
increased markedly (by 18-25%) after 5 min (Fig. 3B) and 
declined subsequently. It was also notable that the amount 
of 94 kDa mGluRip monomer in the low-density fraction 
appeared to increase following PMA and especially quisqualic 
acid treatment. 
Thus there is evidence that there is a reduction in receptor 
number following treatment of the cells with PMA, and that 
mGluRip rapidly enters a light membrane compartment in 
response to quisqualic acid whereas mGluRla does not. 
The data on the redistribution of the cell surface receptor 
obtained from the fractionation of the cell membranes corre-
lates well with that obtained by binding of [125I]R1 and 
[125I]F1, suggesting that the latter was due to receptor inter-
nalisation. 
4. Discussion 
Although the internalisation process has been well charac-
terised for several different G-protein coupled receptors 
(GPCRs) [20], the internalisation of metabotropic glutamate 
receptors (mGluRs) has not previously been reported. Here 
we report two novel findings, namely that mGluRip, but not 
mGluRla undergoes rapid removal from the cell surface fol-
lowing agonist stimulation and that both receptor subtypes 
undergo a slower internalisation following treatment of cells 
with PMA. These responses were observed using two different 
antibodies directed against different N-terminal epitopes and 
were confirmed by membrane fractionation to determine the 
plasma membrane receptor content. 
The splice variants of mGluRl have been reported to show 
little difference in their agonist responses and all of them 
activate phospholipase C in heterologous expression systems 
[2]. However, expression in mammalian cells of the long iso-
form of mGluRl (mGluRla) results in an increase in the 
basal PLC activity with a concomitant doubling of basal in-
ositol phosphate formation [21]. In contrast, when the short 
isoforms mGluRip and mGluRlc were similarly expressed in 
heterologous expression systems basal inositol phosphate pro-
duction was unaffected [21]. Similar results have been reported 
for mGluR5 and its splice variants which utilise the same 
second messenger pathway as mGluRl in transfected cells 
[22]. This has led to the suggestion that the long intracellular 
tail of mGluRla is responsible either for constitutive coupling 
of the receptor to intracellular G-proteins or to the mainte-
nance of the receptor in an activated state. 
Our results suggest that carboxy-terminal domain in 
mGluRl is not only important in the coupling to the G-pro-
tein, but may also be an important determinant in regulating 
agonist induced internalisation. This suggests that intracellu-
lar sequences of both splice variants contains sequences that 
can interact with other cytoplasmic proteins and cause intra-
cellular internalisation in a manner analogous to the interac-
tions of other G-protein coupled receptors with arrestin [20]. 
However, the mGluRls do not contain motifs similar to those 
found in other GPCRs. In particular, the highly conserved 
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D R Y X X V / I X X P L sequence, found in the second intracellular 
loop of G P C R s [23,24], and the highly conserved motif 
NP(X)2,3Y found toward the cytoplasmic face of the putative 
seventh t ransmembrane domain in these proteins [9,25,26] are 
not found in the m G l u R l receptors. This suggests that other 
internalisation sequences remain to be found in this new and 
different group of GPCRs . Additional studies are needed to 
elucidate which amino acids in m G l u R i p are responsible for 
its rapid internalisation in response to agonist. The results 
presented here also suggest that the carboxy-terminal domain 
of these receptors does not play an important role in the 
protein kinase C mediated internalisation of m G l u R l s splice 
variants and that consequently the determinants responsible 
for this internalisation lie elsewhere in the molecule. 
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